Parsons Corporation (PSN): what the price assumes

In the published model solve dated 2026-Q2, anchored at $47.77, Parsons Corporation (PSN) is priced for -2.4% growth. boothcheck publishes no house fair value, target price, or buy/sell rating; individual model outputs and user-controlled scenarios are analytical inputs, not Boothcheck targets. Narrative composed 2026-06-27.

Generated: 2026-08-10 · Exported: 2026-08-12 · Source: https://boothcheck.com/report/PSN

Headline

FieldValue
TickerPSN
CompanyParsons Corporation
Current price$47.78/sh
CompositionFixed-Price 34% / Time-and-Materials 24% / Cost-Plus 42%

What The Price Assumes (Inversion)

The assumption today's price embeds, recovered by inverting the valuation.

FieldValue
Inversion basiswhole-company
Operating margin (value-band context)1.1%
Operating margin today6.4%
Margin compression (value-band)-5.3pp
Implied growth-2.4%
Multiple paid16x operating income

The operating-margin figure is value-band context at year 10: derived from the framework's value band, a separate calculation — not part of the priced-in solve.

Solve inputs: computed at a 7.4% cost of capital with 4% terminal growth over a 5-year stage; each 1pp of cost of capital moves the implied operating-profit growth ~6.9pp.

Reconcile: at the x-ray's 9.3% required return this reads ~9.7%/yr; the models below use their own rates.

How unusual the bet is: within-range

ReferenceValue
vs own history-0.71σ
cohort percentile (of 187 peers)18
implied end-window share0%

Valuation X-Ray

Every valuation family lands below the price. The price therefore sits beyond what those standard frames encode.

How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.

FamilyMedian price/FVModelsReads
Asset2.18x5expensive
Earnings2.04x4expensive
Relative0
Growth1.45x3expensive

Families that call it expensive: Asset, Earnings

The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 7.2%); the inversion above states its own rate.

Per-Model Detail (n=12)

ModelFamilyFVPrice/FVApplicableMethodology
DCF Perpetual GrowthGrowth$32.871.45xyesFCF base $0.4B, growth -7% (input: historical growth), terminal g 0.5%, WACC 7.2%, 5yr projection
DCF Exit MultipleGrowth$49.710.96xyesExit EV/EBITDA: 10.4x / 12.4x / 14.4x (bear / base = today's held flat / bull), 5yr
Relative ValuationRelativenoP/E 35x (static sector reference · 2026-04), scenarios: 29.6x / 35.0x / 40.4x (bear / base = reference held flat / bull), EV/EBITDA 19.96x
Simple DDMGrowthno
Two-Stage DDMGrowthno
Simple Excess ReturnAsset$22.732.10xyesBV/sh $24.44, ROE (TTM) 8.6%, ke 9.3%
Two-Stage Excess ReturnAsset$21.912.18xyes5yr excess ROE then converge to ke=9.3%
Discounted Future Market CapGrowth$24.201.97xyesRev $6.3B, growth -7% (input: historical growth; tapered), Terminal P/S: 0.7x / 0.8x / 0.9x (bear / base = today's held flat / bull, cap 8x)
Growth-Adjusted P/ERelativeno
Margin TrajectoryGrowthno
Earnings Power ValueEarnings$18.562.57xyesNormalized EBIT (5y avg op income, one-time charges added back) $0.30B × (1−20%) / WACC 7.2% → EPV (no growth)
Residual IncomeAsset$21.782.19xyesBV $24.44 + 5yr PV of (ROE (TTM) 8.6% − Kₑ 9.3%) × BV; BV grows 5.6%/yr
Graham NumberAsset$33.901.41xyes√(22.5 × EPS $2.09 × BVPS $24.44) — Graham's conservative floor
EV/EBITDA RelativeRelativenoEBITDA $0.53B × sector EV/EBITDA 25.0x
FCF YieldEarnings$28.741.66xyesFCF $417.1M / Kₑ 9.3% — zero-growth perpetuity
SBC-Adj FCF YieldEarnings$24.411.96xyesSBC-adj FCF $0.37B (FCF $0.42B − SBC $0.04B) capitalized at Kₑ
Ben Graham FormulaEarnings$1.7527.30xyesEPS $2.09 × (8.5 + 2×-5.0%) × (4.4 / 5.3%) (excluded from median)
ROIC-Justified P/BAsset$6.477.38xyesBV $24.44 × (ROIC 1.9% / WACC 7.2%)
P/Sales SectorRelativenoRevenue $6.30B × sector P/S 8.0x
PEG Fair ValueRelativeno
Earnings YieldEarnings$22.592.11xyesEPS $2.09 / required return 9.3% (Rf 4.3% + ERP 5.0%)
Funds From Operations MultipleRelativeno
Clinical Phase NPVGrowthno
MertonAssetno
V5 Mechanicalno

Economic-Unit Decomposition (Sum Of The Parts)

One or more material disclosed units has unresolved economics. Unknown/general is not evidence of homogeneity: segment SOTP is primary but incomplete, consolidated cash flow may remain only a secondary cross-check when every unit shares an enterprise basis, and one sector multiple or target margin is withheld.

UnitRoleValuation basisRevenueReported profitValue evidenceStatus
Federal Solutionsoperatingenterprise$3.2bwithheldunresolved no unit value
Critical Infrastructureoperatingenterprise$3.1bwithheldunresolved no unit value

No total common-equity value is stated. One or more material units lack a supported unit value. The displayed values are an indicative subtotal; consolidated debt and cash cannot be applied to a fraction of the company.

Solvency

FieldValue
Net debt$1.2b
Net debt / NOPAT (after-tax)3.82x
Net debt / operating income (pre-tax)3.06x
Interest coverage7.3x
Share count CAGR (buyback)-1.1%
Burning cashno

Bullet Takeaways

Bull Case

The loudest worry on Parsons is the headline revenue decline, so confront it first. First-quarter 2026 revenue of $1.5 billion was down 4% year over year, which looks like a stalling business until you see why. A single large confidential contract rolled off; excluding it, total revenue rose 8% and organic revenue grew 3%. Federal Solutions revenue grew 12% excluding that contract, driven by demand for cyber, electronic warfare, and space capabilities. So the data undercuts the fear: the underlying business is growing, and the decline is an artifact of one program ending. EPS of $0.79 beat the estimate, adjusted EBITDA margin expanded to a record 10.1%, and total backlog reached a record $9.3 billion. That is not a company in retreat.

The order book is the strongest part of the case. The book-to-bill ratio was 1.4 times in both segments, and the Critical Infrastructure business has now posted 22 consecutive quarters of book-to-bill above 1.0. A book-to-bill consistently above one means new awards are coming in faster than revenue is recognized, which is the leading indicator of future growth for a project business. The 10-K frames the segment dynamics around "the timing and size of the awards issued by our customers" (FY2025 10-K, accession 0001193125-26-045495), and the recent awards keep arriving: post-quarter the company booked $400 million in Other Transaction Agreements, a new classified contract, and a ceiling increase on a national security prime contract.

The valuation makes the setup attractive. The price implies essentially flat operating income, yet the company is growing organically, expanding margins, and sitting on record backlog. The reverse-DCF fair band centers above $117, far above the current $52 (June 27, 2026), which says the market is pricing almost no growth into a business with a strong order pipeline. The two segments contribute roughly evenly to earnings, with Federal Solutions and Critical Infrastructure together making up the EBITDA base in a 46% and 54% split (accession 0001193125-26-045495), giving Parsons exposure to both national-security spending and the infrastructure investment cycle. For a company this well-positioned, paying a price that assumes stagnation is the core of the bull thesis.

Bear Case

The fragile assumption baked into Parsons is that its government revenue keeps flowing smoothly, and that is exactly the assumption most exposed to forces outside the company's control. The first-quarter revenue decline, even if driven by one confidential contract rolling off, is a live reminder of the risk: large government programs end, get recompeted, or get cut, and when they do the revenue disappears in a lump. A book-to-bill above one is encouraging, but backlog is not cash, and the conversion of that $9.3 billion into revenue depends on funding decisions, appropriations timing, and the pace at which customers issue task orders. A defense and infrastructure contractor lives and dies by the federal budget cycle.

The contract economics carry their own hazard. Parsons takes on fixed-price work where, as the 10-K explains, the company "receive[s] the full benefit of any cost savings, but they also generally involve greater financial risk because we bear the risk of any cost overruns" (FY2025 10-K, accession 0001193125-26-045495). On large, multi-year engineering projects, a cost overrun can erase the margin on a whole contract, and the record 10.1% margin posted in the first quarter is a high-water mark that sets a tough comparison. If a few projects run over, the margin story that is currently supporting the stock reverses.

The valuation frames are more cautious than the bull narrative allows. The asset-based, earnings-power, and growth-DCF frames all read the price as expensive on current economics; only the relative-multiple frame justifies it. That is a thin base of support, and it depends on the market continuing to award defense-services peers a premium multiple. Net debt near three times operating income is manageable but not trivial, and the business has grown partly through acquisition, which adds integration risk and goodwill. The bear case is not that Parsons is a bad business; it is that the price assumes uninterrupted execution and funding, and government-dependent businesses rarely deliver uninterrupted anything.

Valuation

Parsons is priced conservatively relative to its own results, which is what makes the valuation interesting. At about $52 the stock is roughly 17 times trailing operating income, which inverts to operating income growth of about minus half a percent a year over five years. In other words, the price assumes the business essentially flatlines. Against a company posting record backlog, a 1.4 times book-to-bill, and record margins, that is a low bar, and the overall priced-in level reads as within range rather than stretched.

The family pattern is mixed and worth reading carefully. The relative-multiple frame supports the price, while the asset-based, earnings-power, and growth-DCF frames read it as expensive on current economics. The reasonable-growth band built from the inversion is unusual here: it runs from a low near $81 to a base and high at about $117, both well above the current price. The current operating margin of 6.4% leaves room for the margin expansion the company has been delivering to add value.

The honest framing is that the methods see more value than the price reflects, provided the order book converts. The risk is concentration and execution rather than solvency, since leverage is moderate and coverage is comfortable. A buyer at this price is underwriting that Parsons keeps converting its record backlog into revenue at healthy margins, and is being paid to take the government-funding and cost-overrun risk that comes with the territory. If the conversion happens, the reverse-DCF says there is meaningful room between the price and fair value; if it stalls, the relative-multiple support is the only floor.

Catalysts

The recent quarter set a constructive tone despite a noisy headline. First-quarter 2026 EPS of $0.79 beat the $0.69 estimate, even as revenue of $1.5 billion slipped 4% on the roll-off of a large confidential contract; excluding that contract, total revenue rose 8% and Federal Solutions grew 12%. Total and funded backlog reached records of $9.3 billion and $6.6 billion, the book-to-bill ratio was 1.4 times in both segments, and adjusted EBITDA margin expanded to a record 10.1%. Management reiterated full-year 2026 guidance. The next earnings reports are the checkpoints for whether organic growth reaccelerates as the confidential contract comparison eases.

The award flow is the catalyst to watch. Demand for cyber, electronic warfare, and space capabilities is driving Federal Solutions, and Critical Infrastructure has posted 22 consecutive quarters of book-to-bill above 1.0. Post-quarter the company added $400 million in Other Transaction Agreements, a new single-award classified contract with a $184 million ceiling, and an $87 million ceiling increase on a national security prime contract. Each large new award supports the conversion of backlog into future revenue, so the cadence of bookings is the leading indicator for the stock.

The risks run through the budget and the project ledger. Federal funding decisions, appropriations timing, and the pace of task orders all affect how quickly backlog becomes revenue. Fixed-price contracts carry cost-overrun risk that can hit margins on individual projects, and the record margin sets a high bar to repeat. A government shutdown, a program cut, or a stumble on a large project would each weigh on a stock whose price already assumes little growth but whose recent strength has raised expectations.

Peer Cohorts (Per Segment, With Filing Citations)

Federal Solutions (reported)

Critical Infrastructure (reported)

Methodology Note

Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.

View the full interactive PSN report on boothcheck